Today: 27 June 2026
BAE Systems share price today: Moody’s upgrade, fresh buyback filing keep BA stock in focus
6 February 2026
1 min read

BAE Systems share price today: Moody’s upgrade, fresh buyback filing keep BA stock in focus

London, Feb 6, 2026, 09:10 (GMT) — Regular session

  • BAE Systems shares edged up 0.2% in early London trading
  • Moody’s raised BAE’s issuer rating to A3 and set the outlook to stable
  • Company revealed an additional portion of its ongoing share repurchase program

BAE Systems shares ticked up slightly in early London trade on Friday, gaining 0.16% to 1,859.5 pence.

The FTSE 100 defence contractor is entering a phase where investors demand concrete figures: cash flow, margins, and how quickly orders convert into revenue. Its stock remains a key gauge of market appetite for defence companies.

A credit-rating upgrade is crucial now since it can lower borrowing costs and attract a broader range of bond investors, even for firms that already have easy capital access. The buyback is significant too: cutting the number of shares outstanding can boost earnings per share.

Moody’s Ratings raised BAE’s long-term issuer and senior unsecured ratings to A3 from Baa1, shifting the outlook to stable from positive, according to a Moody’s note reported by Investing.com. The agency cited a robust defence market and forecasted strong credit metrics, including free cash flow of around 1 billion pounds annually in 2026-2027.

BAE revealed a fresh batch of buybacks, purchasing 115,039 shares for cancellation on Feb. 5. The shares went for between 1,839.5 pence and 1,882.5 pence, with a volume-weighted average price of 1,860.32 pence — reflecting the day’s average price weighted by trade size.

GXO has renewed and expanded its UK contract with BAE for another six years, focusing on the company’s naval operations. The logistics firm will handle warehousing and materials at BAE’s Scotstoun and Govan shipyards along the River Clyde, where Type 26 frigates are being built. BAE executive Jen Blee said the deal “will help us continue to improve the efficiency of our supply chain and shipbuilding operations.” GlobeNewswire

The wider market leaned lower, with the FTSE 100 dropping 0.5% by 0836 GMT. Sterling, on the other hand, showed strength, according to Investing.com.

Defence stocks have been moving in line with geopolitical developments. British Defence Secretary John Healey revealed that NATO allies are considering new Arctic security strategies ahead of the Feb. 12 NATO defence ministers meeting, Reuters reported.

Investors remain wary of short-term disruptions for manufacturers. Unite, one of the UK’s largest unions, announced this week that over 1,200 BAE workers in northwest England are set to strike over pay. BAE described its offer as “market-leading” and said it expects production lines to keep running. Reuters

The stock hasn’t followed a clear path this week. Shares dropped roughly 3% on Wednesday, highlighting the rapid shifts in sentiment between defense demand and overall risk appetite.

BAE is set to release its full-year results on Feb. 18. Investors will be paying close attention to any changes in guidance, cash flow, dividend plans, and the speed of share buybacks.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next
Previous Story

NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next

Ford stock slips before market open as EV sales dive and Geely talks linger
Next Story

Ford stock slips before market open as EV sales dive and Geely talks linger

Go toTop